Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy (SMART) in Asthma Patients Across Asia: SMARTASIA

NCT00939341 Phase 4 COMPLETED Results posted

The purpose of this study is to compare whether Symbicort Maintenance \& Reliever Therapy (SMART) is more effective in uncontrolled asthmatic patients than their current therapy in a real life situation.

Details

Lead sponsor	AstraZeneca
Phase	Phase 4
Status	COMPLETED
Enrolment	862
Start date	2009-07
Completion	2010-08

Conditions

• Asthma

Interventions

• Symbicort (Budesonide/Formoterol)

Primary outcomes

• Change in Asthma Control Questionnaire (ACQ(5)) Score From Baseline at a Regional Level — Baseline and 12 weeks
  Participants' levels of asthma control were scored on a 7-point Likert scale from 0 to 6, whereby 0 represents good control and 6 represents poor control of asthma. The regional mean change of overall ACQ(5) score were calculated as change from baseline (Week 0) to the average during the treatment period (mean of scores at Week 4, Week 8, Week 12).

Countries

China, India, Indonesia, Taiwan, Thailand